All In MedTech

Device Trial Radar · NCT05572047

Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

101

Actual

Start

Oct 11, 2022

Primary completion

Apr 24, 2026

Study completion Apr 24, 2026

Sponsor

Lead sponsor
Arga Medtech SANot on our public-company list
Sponsor type
Industry
First posted
Oct 7, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficiency of the Arga Medtech CSE Ablation System in the treatment of atrial fibrillation.

Conditions

  • Atrial Fibrillation

Interventions

  • Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation SystemDevice

    Use of coherent sine-burst electroporation to ablate paroxysmal and persistent AF

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serious system and procedure-related eventsTime frame: Within one week (7 days) post-procedure)
  2. Procedural SuccessTime frame: Acute and/or up to 90 days post procedure
  3. Chronic isolation of the pulmonary veinsTime frame: 90 to 180 days post index procedure

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • University Hospital of Split

    Split, Croatia

  • KBC Zagreb

    Zagreb, Croatia

  • Israeli-Georgian Medical Research Clinic Helthycore Ltd

    Tbilisi, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.